샘플 요청 목록

 카트 문의
시장보고서
상품코드
1787207

미오글로빈 시장

Myoglobin
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 268 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 미오글로빈 시장은 2030년까지 1억 1,470만 달러에 이를 전망

2024년에 1억 달러로 추정되는 미오글로빈 세계 시장은 2030년에는 1억 1,470만 달러에 이르고, 분석 기간인 2024-2030년 CAGR은 2.3%를 보일 것으로 예측됩니다. 본 보고서에서 분석한 부문 중 하나인 인간 미오글로빈은 CAGR 1.7%를 나타내고, 분석 기간 종료시에는 7,230만 달러에 이를 것으로 예측됩니다. 동물 미오글로빈 분야의 성장률은 분석 기간중 CAGR 3.4%로 추정됩니다.

미국 시장은 2,730만 달러로 추정, 중국은 CAGR4.4%로 성장 예측

미국의 미오글로빈 시장은 2024년에는 2,730만 달러로 추정됩니다. 세계 2위 경제대국인 중국은 2030년까지 2,170만 달러 규모에 이를 것으로 예측되며, 분석 기간인 2024-2030년 CAGR은 4.4%로 추정됩니다. 기타 주목해야 할 지역별 시장으로는 일본과 캐나다가 있으며, 분석 기간중 CAGR은 각각 0.9%와 1.7%를 보일 것으로 예측됩니다. 유럽에서는 독일이 CAGR 1.2%를 나타낼 전망입니다.

세계의 미오글로빈 시장 - 주요 동향과 촉진요인 정리

미오글로빈이 의료 및 식품 산업에서 점점 더 중요해지는 이유는 무엇인가?

미오글로빈은 근육 조직에 함유된 헴 단백질로, 산소 수송과 저장에 중요한 역할을 하기 때문에 의료 산업과 식품 산업 모두에서 큰 지지를 받고 있습니다. 의료 분야에서 미오글로빈은 특히 심근경색이나 횡문근융해증과 같은 근육 손상을 감지하는 중요한 바이오마커로 작용하고 있습니다. 심혈관 질환의 유병률 증가로 인해 정확한 진단 도구에 대한 수요가 증가하고 있으며, 미오글로빈 기반 검사의 성장을 주도하고 있습니다. 한편, 식품 산업에서 미오글로빈은 육류의 색과 품질을 결정하는 중요한 요소로 소비자의 취향과 구매 행동에 영향을 미칩니다. 신선하고 고품질의 육류 제품에 대한 수요가 크게 증가함에 따라 식품 과학자들은 육류의 저장성을 높이기 위해 미오글로빈 수치를 안정화시킬 수 있는 방법을 모색하고 있습니다. 또한, 식물성 육류 및 배양육 분야에서는 전통 육류의 색과 풍미를 재현하는 미오글로빈의 역할이 연구되고 있으며, 그 시장 용도는 더욱 확대되고 있습니다. 연구가 진행됨에 따라 미오글로빈의 다양한 기능적 특성은 의료 및 식품 산업의 발전을 계속 형성하고 있습니다.

기술 혁신은 미오글로빈의 검출과 응용을 어떻게 개선하고 있는가?

기술의 발전은 미오글로빈의 검출, 추출 및 응용을 크게 개선하여 다양한 분야에서의 관련성을 높이고 있습니다. 진단학에서는 차세대 바이오센서와 면역 측정 기술을 통해 미오글로빈을 심장 및 근육 질환의 조기 지표로 신속하고 정확하게 검출할 수 있게 되었습니다. 이러한 개발은 적시 진단이 환자의 예후를 개선하는 응급 의료 분야에서 특히 중요합니다. 식품 산업에서는 분광법과 크로마토그래피 기술의 혁신으로 미오글로빈 수준 분석이 최적화되어 육류의 품질과 색조가 일정하게 유지되고 있습니다. 또한, 합성생물학과 단백질 공학의 발달로 유전자 변형 미오글로빈의 생산이 가능해지면서 동물성 제품의 맛과 질감을 재현하기 위해 실험실에서 자란 대체육에 사용되는 경우가 많아지고 있습니다. 또한, 냉동 보존과 안정화제의 발전으로 미오글로빈의 저장 기간이 연장되어 상업적 응용이 더욱 현실화되었습니다. 기술이 계속 발전함에 따라 미오글로빈의 진단 및 기능적 용도가 확대되어 시장의 성장과 다양화를 촉진할 것으로 예측됩니다.

미오글로빈 활용의 새로운 트렌드는?

건강 지향과 지속 가능한 식품 선택에 대한 관심이 높아지면서 미오글로빈의 활용, 특히 대체 단백질 공급원의 새로운 트렌드에 영향을 미치고 있습니다. 식물성 육류와 배양육의 채택이 증가하면서 기존 육류의 감각적 특징을 모방하는 중요한 성분으로 미오글로빈에 대한 관심이 높아지고 있습니다. 배양육을 개발하는 기업들은 미오글로빈을 도입하여 맛과 색상의 안정성을 높이고 있으며, 대체 단백질 공급원으로 전환하고 있는 소비자들에게 더욱 매력적인 제품이 되고 있습니다. 의료 분야에서는 미오글로빈의 산소 결합 특성을 이용하여 세포의 생존율과 조직공학 기술을 향상시켜 재생의료 및 근육 복구 요법에 미오글로빈을 이용한 연구가 활발히 진행되고 있습니다. 미오글로빈 분석에 AI와 머신러닝의 통합은 질병 진단과 식품 품질 평가를 위한 예측 모델링을 가능하게 하여 인기를 끌고 있습니다. 또한, 소비자들이 식품 조달에 대한 투명성을 요구하는 가운데, 미오글로빈을 기반으로 한 신선도 지표는 공급망 가시성을 높이고 식품 폐기물을 줄이기 위해 연구되고 있습니다. 이러한 새로운 추세는 미오글로빈이 건강과 식품 혁신의 양면에서 점점 더 중요해지고 있으며, 장기적인 시장 잠재력을 보여주고 있습니다.

시장 성장 촉진요인은 무엇인가?

미오글로빈 시장의 성장은 진단 기술의 발전, 고품질 육류에 대한 소비자 수요 증가, 대체 단백질 산업의 확대 등 몇 가지 중요한 요인에 의해 주도되고 있습니다. 심혈관 질환의 부담이 증가함에 따라 조기 진단 도구에 대한 수요가 증가하고 있으며, 미오글로빈은 의료 검사에서 중요한 바이오마커로 자리매김하고 있습니다. 또한, 전 세계 육류 소비량이 증가함에 따라 효율적인 육류 품질 평가 기술의 필요성이 증가하고 있으며, 미오글로빈은 육류의 신선도와 매력을 결정하는 데 있어 매우 중요한 역할을 하고 있습니다. 실험실 재배 및 식물 유래 육류 제품의 채택이 가속화됨에 따라 미오글로빈의 기능적 특성에 대한 관심이 더욱 높아져 연구 개발이 활발해지고 있습니다. 대체 단백질과 지속가능성을 중시하는 식품 혁신에 대한 규제 당국의 지원도 시장 확대에 기여하고 있습니다. 또한, 생명공학 및 생물공학에 대한 투자로 미오글로빈의 새로운 응용, 특히 합성생물학 및 기능성 식품 소재에 대한 응용이 가능해졌습니다. 산업계가 건강, 지속가능성, 혁신을 최우선 과제로 삼고 있는 가운데, 미오글로빈 시장은 여러 분야에서 그 가치를 강화하며 크게 성장하고 있습니다.

부문

미오글로빈 타입(인간미오글로빈, 동물 미오글로빈);최종사용자(병원 최종사용자, 진단실험실 최종사용자, 연구 및 학술기관 최종사용자)

조사 대상 기업 예

  • Abnova Corporation
  • BBI Solutions
  • Bio-Rad Laboratories, Inc.
  • BODITECH MED INC.
  • Bon Opus Biosciences, LLC.
  • Calzyme Laboratories, Inc.
  • Goldsite Diagnostics Inc.
  • Guangzhou KOFA Biotechnology Co., Ltd.
  • HyTest Ltd.
  • Innovative Research
  • Laboratory Corporation of America Holdings
  • Lee BioSolutions(Medix Biochemica)
  • MedchemExpress LLC
  • Merck KGaA
  • MSE Supplies LLC
  • OriGene Technologies, Inc.
  • R&D Systems(Bio-Techne)
  • Scripps Laboratories
  • Thermo Fisher Scientific Inc.
  • Worthington Biochemical Corporation

AI 통합

Global Industry Analysts는 유효한 전문가 컨텐츠와 AI툴에 의해서, 시장 정보와 경쟁 정보를 변혁하고 있습니다.

Global Industry Analysts는 LLM나 업계 고유 SLM를 조회하는 일반적인 규범에 따르는 대신에, 비디오 기록, 블로그, 검색 엔진 조사, 방대한 양의 기업, 제품/서비스, 시장 데이터 등, 전 세계 전문가로부터 수집한 컨텐츠 리포지토리를 구축했습니다.

관세 영향 계수

Global Industry Analysts는 본사 소재지, 제조거점, 수출입(완제품 및 OEM)을 기준으로 기업의 경쟁력 변화를 예측했습니다. 이러한 복잡하고 다면적인 시장 역학은 수익원가(COGS) 증가, 수익성 하락, 공급망 재편 등 미시적, 거시적 시장 역학 중에서도 특히 경쟁사들에게 영향을 미칠 것으로 예측됩니다.

목차

제1장 조사 방법

제2장 주요 요약

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

LSH 25.08.18

Global Myoglobin Market to Reach US$114.7 Million by 2030

The global market for Myoglobin estimated at US$100.0 Million in the year 2024, is expected to reach US$114.7 Million by 2030, growing at a CAGR of 2.3% over the analysis period 2024-2030. Human Myoglobin, one of the segments analyzed in the report, is expected to record a 1.7% CAGR and reach US$72.3 Million by the end of the analysis period. Growth in the Animal Myoglobin segment is estimated at 3.4% CAGR over the analysis period.

The U.S. Market is Estimated at US$27.3 Million While China is Forecast to Grow at 4.4% CAGR

The Myoglobin market in the U.S. is estimated at US$27.3 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$21.7 Million by the year 2030 trailing a CAGR of 4.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 0.9% and 1.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.2% CAGR.

Global Myoglobin Market - Key Trends & Drivers Summarized

Why Is Myoglobin Gaining Significance in Medical and Food Industries?

Myoglobin, a heme protein found in muscle tissues, has gained significant traction in both medical and food industries due to its crucial role in oxygen transport and storage. In the medical field, myoglobin serves as a key biomarker for detecting muscle damage, particularly in conditions such as myocardial infarction and rhabdomyolysis. The rising prevalence of cardiovascular diseases has heightened demand for accurate diagnostic tools, driving growth in myoglobin-based testing. Meanwhile, in the food industry, myoglobin is a critical factor in determining meat color and quality, influencing consumer preferences and purchasing behavior. The demand for fresh and high-quality meat products has increased significantly, prompting food scientists to explore methods of stabilizing myoglobin levels to enhance meat preservation. Additionally, the growing plant-based and cultured meat sectors are studying myoglobin’s role in replicating the color and flavor of traditional meat, further expanding its market applications. As research advances, myoglobin’s diverse functional attributes continue to shape developments in both the healthcare and food industries.

How Are Technological Innovations Improving Myoglobin Detection and Application?

Technological advancements have significantly improved the detection, extraction, and application of myoglobin, enhancing its relevance across various sectors. In diagnostics, next-generation biosensors and immunoassay techniques have led to rapid and precise detection of myoglobin as an early indicator of cardiac and muscular disorders. These developments are particularly crucial in emergency medicine, where timely diagnosis can improve patient outcomes. In the food industry, innovations in spectroscopy and chromatography techniques have optimized the analysis of myoglobin levels, ensuring consistent meat quality and coloration. Additionally, the rise of synthetic biology and protein engineering has enabled the production of recombinant myoglobin, which is increasingly used in lab-grown meat alternatives to replicate the taste and texture of animal-derived products. Furthermore, advancements in cryopreservation and stabilizing agents are prolonging myoglobin’s shelf life, making it more viable for commercial applications. As technology continues to evolve, myoglobin's diagnostic and functional applications are expected to expand, driving further market growth and diversification.

What Are the Emerging Trends in Myoglobin Utilization?

The increasing focus on health-conscious and sustainable food choices has influenced new trends in myoglobin utilization, particularly in alternative protein sources. The rising adoption of plant-based and cultured meat has driven interest in myoglobin as a key ingredient for mimicking the sensory characteristics of conventional meat. Companies developing lab-grown meat are incorporating myoglobin to enhance flavor and color stability, making these products more appealing to consumers transitioning to alternative protein sources. In the medical sector, myoglobin-based research is expanding into regenerative medicine and muscle repair therapies, leveraging its oxygen-binding properties to improve cell viability and tissue engineering techniques. The integration of AI and machine learning in myoglobin analysis is also gaining traction, enabling predictive modeling for disease diagnosis and food quality assessment. Additionally, as consumers demand greater transparency in food sourcing, myoglobin-based freshness indicators are being explored to enhance supply chain visibility and reduce food waste. These emerging trends highlight myoglobin’s increasing importance in both health and food innovation, signaling long-term market potential.

What Factors Are Driving Market Growth?

The growth in the myoglobin market is driven by several key factors, including advancements in diagnostic technology, increasing consumer demand for high-quality meat, and the expansion of alternative protein industries. The growing burden of cardiovascular diseases has spurred demand for early diagnostic tools, positioning myoglobin as a crucial biomarker in medical testing. Additionally, the rise in global meat consumption has intensified the need for efficient meat quality assessment techniques, with myoglobin playing a pivotal role in determining meat freshness and appeal. The accelerating adoption of lab-grown and plant-based meat products has further propelled interest in myoglobin’s functional properties, leading to increased research and development efforts. Regulatory support for alternative proteins and sustainability-driven food innovations is also contributing to market expansion. Furthermore, investments in biotechnology and bioengineering are enabling novel applications of myoglobin, particularly in synthetic biology and functional food ingredients. As industries continue to prioritize health, sustainability, and innovation, the myoglobin market is set for significant growth, reinforcing its value across multiple sectors.

SCOPE OF STUDY:

The report analyzes the Myoglobin market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Myoglobin Type (Human Myoglobin, Animal Myoglobin); End-Use (Hospitals End-Use, Diagnostic Laboratories End-Use, Research & Academic Institutes End-Use)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 34 Featured) -

  • Abnova Corporation
  • BBI Solutions
  • Bio-Rad Laboratories, Inc.
  • BODITECH MED INC.
  • Bon Opus Biosciences, LLC.
  • Calzyme Laboratories, Inc.
  • Goldsite Diagnostics Inc.
  • Guangzhou KOFA Biotechnology Co., Ltd.
  • HyTest Ltd.
  • Innovative Research
  • Laboratory Corporation of America Holdings
  • Lee BioSolutions (Medix Biochemica)
  • MedchemExpress LLC
  • Merck KGaA
  • MSE Supplies LLC
  • OriGene Technologies, Inc.
  • R&D Systems (Bio-Techne)
  • Scripps Laboratories
  • Thermo Fisher Scientific Inc.
  • Worthington Biochemical Corporation

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Tariff Impact on Global Supply Chain Patterns
    • Myoglobin - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Use of Myoglobin as a Biomarker Throws the Spotlight on Early Detection of Cardiac Events
    • Expansion of Clinical Research in Muscle and Tissue Oxygenation Drives Adoption in Diagnostics
    • Growth in Personalized and Preventive Healthcare Strengthens Business Case for Myoglobin Testing
    • Increased Prevalence of Cardiovascular Diseases Spurs Demand for Rapid Myoglobin Detection Kits
    • Advancements in Immunoassay and Biosensor Technologies Enhance Sensitivity and Diagnostic Accuracy
    • Integration of Myoglobin Testing in Point-of-Care Platforms Expands Usage in Emergency Settings
    • Emerging Applications in Sports Medicine and Muscle Injury Monitoring Drive Market Diversification
    • Research on Myoglobin Kinetics Supports Its Use in Trauma and Critical Care Diagnostics
    • Availability of Rapid, Multiplexed Testing Devices Enhances Screening Efficiency in Hospital Settings
    • Global Expansion of Cardiac Biomarker Panels Includes Myoglobin as a Key Early Indicator
    • Public Health Campaigns on Heart Disease Prevention Sustain Demand for Routine Screening
    • Technological Innovations in Lab-on-a-Chip Devices Propel Miniaturization and Home-Based Testing
    • Strategic Collaborations Between Biotech Firms and Hospitals Strengthen Commercial Pathways
    • Use of Myoglobin in Veterinary Diagnostics Opens Parallel Market Growth in Animal Healthcare
    • Growth in Aging Populations and Sedentary Lifestyles Drives Market Need for Cardiovascular Biomarkers
    • Increased Emphasis on Cost-Effective, Rapid Diagnostics Fuels Use of Myoglobin in Low-Income Markets
    • Multiparametric Diagnostic Approaches Enhance Myoglobin's Relevance in Comprehensive Cardiac Panels
    • Regulatory Approvals for High-Sensitivity Myoglobin Assays Accelerate Adoption Across Regions
    • Globalization of IVD Platforms Drives Inclusion of Myoglobin in Emergency and Pre-Hospital Kits
    • Data Integration and EHR-Linked Diagnostics Support Better Risk Stratification Using Myoglobin Biomarkers
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Myoglobin Market Analysis of Annual Sales in US$ for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Human Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Human Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Human Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Animal Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Animal Myoglobin by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Animal Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Diagnostic Laboratories End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Diagnostic Laboratories End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Research & Academic Institutes End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Research & Academic Institutes End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 20: USA Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 21: USA Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 22: USA 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 23: USA Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 26: Canada Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 27: Canada Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 28: Canada 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • JAPAN
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 32: Japan Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Japan Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 34: Japan 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • CHINA
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 38: China Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 39: China Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 40: China 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 41: China Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • EUROPE
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 44: Europe Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 45: Europe Historic Review for Myoglobin by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 46: Europe 15-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • FRANCE
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 53: France Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 54: France Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 55: France 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 56: France Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • GERMANY
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 59: Germany Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Germany Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 61: Germany 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 65: Italy Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Italy Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 67: Italy 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 71: UK Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 72: UK Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 73: UK 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 74: UK Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 77: Spain Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Spain Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 79: Spain 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 82: Spain 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 83: Russia Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Russia Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 85: Russia 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 88: Russia 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 89: Rest of Europe Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Rest of Europe Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 91: Rest of Europe 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of Europe 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 95: Asia-Pacific Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 96: Asia-Pacific Historic Review for Myoglobin by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 97: Asia-Pacific 15-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 100: Asia-Pacific 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 103: Asia-Pacific 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 104: Australia Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 105: Australia Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 106: Australia 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 109: Australia 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • INDIA
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 110: India Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 111: India Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 112: India 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 113: India Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 115: India 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 116: South Korea Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 117: South Korea Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 118: South Korea 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 121: South Korea 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 122: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 123: Rest of Asia-Pacific Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 124: Rest of Asia-Pacific 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 128: Latin America Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 129: Latin America Historic Review for Myoglobin by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 130: Latin America 15-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 133: Latin America 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 136: Latin America 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 137: Argentina Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 138: Argentina Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 139: Argentina 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 142: Argentina 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 143: Brazil Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Brazil Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 145: Brazil 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 148: Brazil 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 149: Mexico Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Mexico Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 151: Mexico 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 154: Mexico 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 155: Rest of Latin America Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Rest of Latin America Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 157: Rest of Latin America 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 160: Rest of Latin America 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 161: Middle East Recent Past, Current & Future Analysis for Myoglobin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
    • TABLE 162: Middle East Historic Review for Myoglobin by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 163: Middle East 15-Year Perspective for Myoglobin by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 166: Middle East 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 169: Middle East 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 170: Iran Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 171: Iran Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 172: Iran 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 175: Iran 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 176: Israel Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Israel Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 178: Israel 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 181: Israel 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 182: Saudi Arabia Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Saudi Arabia Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 184: Saudi Arabia 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 187: Saudi Arabia 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 188: UAE Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 189: UAE Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 190: UAE 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 193: UAE 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 194: Rest of Middle East Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Rest of Middle East Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 196: Rest of Middle East 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 199: Rest of Middle East 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030
  • AFRICA
    • Myoglobin Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 200: Africa Recent Past, Current & Future Analysis for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 201: Africa Historic Review for Myoglobin by Myoglobin Type - Human Myoglobin and Animal Myoglobin Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 202: Africa 15-Year Perspective for Myoglobin by Myoglobin Type - Percentage Breakdown of Value Sales for Human Myoglobin and Animal Myoglobin for the Years 2015, 2025 & 2030
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Myoglobin by End-Use - Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use Markets - Independent Analysis of Annual Sales in US$ for Years 2015 through 2023 and % CAGR
    • TABLE 205: Africa 15-Year Perspective for Myoglobin by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Diagnostic Laboratories End-Use and Research & Academic Institutes End-Use for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제